Cabergoline is a new drug. Its primary purpose is to lower prolactin in patients with a pituitary tumor.
This medication is used to treat certain hormone problems (excess prolactin). The drug is used to reduce or prevent breast milk production, except after childbirth (Postpartum).
This drug may also be used for Parkinson's disease, prolactin-producing tumors and to adjust various hormone levels in certain diseases (ovarian diseases).